Home » Topics » Pharmaceuticals » Research and Development

April 7, 2020
Izana Begins Trial of Rheumatoid Arthritis Drug for COVID-19
Namilumab is currently in late-stage clinical development for the treatment of rheumatoid arthritis and ankylosing spondylitis.
April 7, 2020
GSK and Vir Biotech Partner on Coronavirus Treatments
The companies will also work to develop vaccines for other viruses.
April 7, 2020
Gilead Ramps Up Remdesivir Production as More Trials Emerge
Gilead CEO Daniel O’Day announced that the company is ramping up production of its antiviral remdesivir for COVID-19 and hopes to have 500,000 treatment courses by October, and more than 1 million treatment courses by the end of the year.

April 7, 2020
Inovio Initiates Phase 1 Trial of COVID-19 Vaccine
April 3, 2020
Drugmakers Repurpose Existing Therapies for COVID-19
April 3, 2020
FDA Coordinates Nationwide Effort on Blood-Based Therapies for COVID-19
April 3, 2020
Amgen and Adaptive Biotechnologies Partner on COVID-19 Therapeutic
April 3, 2020
Novartis Plans Clinical Trial of Jakavi in Severe COVID-19 Patients

April 3, 2020
Emergent BioSolutions Partners with HHS for Plasma-Derived COVID-19 Treatment
April 2, 2020
Chinese Trial Suggests Hydroxychloroquine Helps COVID-19 Patients
April 2, 2020
Big Tobacco has COVID-19 Vaccine Candidates in the Pipeline
April 2, 2020
Gilead Begins Remdesivir Trials in the U.K.
April 2, 2020
Australia Begins Testing COVID-19 Vaccines

Products

Events

Pages